Safety and Efficacy Study of Cylindrical Abdominoperineal Resection to Treat Rectal Cancer
Study Details
Study Description
Brief Summary
The purpose of this study is to determine whether cylindrical abdominoperineal resection is effective in the treatment of advanced very low rectal cancer
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Abdominoperineal resection (APR) is still a common operation in patients with tumours less than 6 cm from the anal verge. The perineal phase of APR is a difficult part of the operation, often done with the patient in the supine position.The risk of inadvertent bowel perforation is high, the resulting specimen frequently has a waist at the lower border of the mesorectum, and the circumferential resection margin (CRM) is often close to the rectal muscle tube. The cylindrical APR may be performed via an extended posterior perineal approach, that aims to create a more cylindrical specimen without a waist. The potential benefit of this technique is a reduction in the risk of bowel perforation and tumour involvement of the CRM, and thus in the risk of local recurrence.
Perineal wounds in patients following APR are at considerable risk for infection, dehiscence and delayed healing when closed primarily. This can be further increased in patients who have received neoadjuvant chemoradiation therapy. The adoption of extended resection, such as the cylindrical APR, may cause additional risks. The use of acellular biomaterials, including human acellular dermal matrix (HADM) has drawn great interest for the complex abdominal wall reconstruction.
The purpose of this study is to determine whether cylindrical abdominoperineal resection is effective in the treatment of advanced very low rectal cancer, and to determine the initial results of pelvic reconstruction using human acellular dermal matrix after cylindrical abdominoperineal resection.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
cylindrical abdominoperineal resection patients underwent cylindrical abdominoperineal resection for advanced very low rectal cancer |
Procedure: cylindrical abdominoperineal resection
Extended abdominoperineal resection with human acellular dermal matrix reconstruction of the pelvic floor for rectal cancer
Other Names:
|
abdominoperineal resection patients underwent conventional abdominoperineal resection for advanced very low rectal cancer |
Outcome Measures
Primary Outcome Measures
- postoperative complications [08/01/2011]
Secondary Outcome Measures
- 3-years overall survival [08/01/2013]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Tumor within 6 cm of the anal verge, or with very narrow pelvis
-
T3-T4 as determined by preoperative MRI or endorectal ultrasonography examination, or a low tumor is fixed or tethered at rectal examination
-
Absence of distant metastases
-
Absence of intestinal obstruction
Exclusion Criteria:
-
T1-T2 as determined by preoperative MRI or endorectal ultrasonography examination
-
with distant metastases
-
with intestinal obstruction
-
pregnancy or lactation
-
allergic constitution to heterogeneous protein
-
with operation contraindication
-
with mental disorder
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Beijing Luhe Hospital | Beijing | Beijing | China | 100000 |
2 | General Surgery, Beijing Chao Yang Hospital | Beijing | Beijing | China | 100020 |
3 | The first Affiliated Hospital of Zhengzhou University | Zhengzhou | Henan | China | 450003 |
4 | Zhongnan Hospital, Wuhan University | Wuhan | Hubei | China | 430077 |
5 | Shenyang Anorectal Hospital | Shenyang | Liaoning | China | 110002 |
6 | General Surgery, Shandong Provincial Hospital | Jinan | Shandong | China | 250022 |
7 | Shandong Cancer Hospital and Institute | Jinan | Shandong | China | 250117 |
Sponsors and Collaborators
- Beijing Chao Yang Hospital
- Shandong Provincial Hospital
- Shandong Cancer Hospital and Institute
- The First Affiliated Hospital of Zhengzhou University
- Wuhan University
- Shenyang Anorectal Hospital
- Beijing Luhe Hospital
Investigators
- Study Chair: Zhen Jun Wang, M.D., Beijing Chao Yang Hospital
- Principal Investigator: Yong Dai, M.D., Shandong Provincial Hospital
- Principal Investigator: Heng Ma, M.D., Shandong Cancer Hospital and Institute
- Principal Investigator: Qun Qian, M.D., Zhong Nan Hospital, Wuhan University
- Principal Investigator: Xian Dong Zeng, M.D., Shenyang Anorectal Hospital
- Principal Investigator: Jian Hua Cai, M.D., Beijing Luhe Hospital
- Principal Investigator: Wei Tang Yuan, M.D., The First Affiliated Hospital of Zhengzhou University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CAPR0668